PPI network-based models |
Evaluate drug synergy based on network topology relations of targets |
Drug targets; |
Complex network; |
Synergistic drug combinations; |
Protein interactions |
Network pharmacology |
Synergistic targets |
Pathway-based models |
Simulate the dynamic changes of pathway and identify synergy-specific pathway structures |
Drug targets; |
Ordinary differential equations; |
Dose–response assessment of drug synergy; |
Pathway structures; |
Network motif recognition |
Synergy-specific |
Dynamic changes of each pathway component; |
network motifs in pathways |
Drug interactions |
Drug similarity-based models |
Construct classification models based on various drug similarities |
Drug properties like targets, structures, indication, et al. |
Similarity calculation; |
Synergistic drug combinations; |
Feature selection; |
Distinctive features for drug combination |
Classification model |
Omic-based models |
Apply “omic” data to calculate drug associations; or rebuild the synergy-dependent pathways |
Responses to drugs in the form of “omic” data |
Reverse engineering of biological networks; |
Synergistic drug combinations; |
“Omic” data similarity calculation; |
Biological networks; |
Classification model |